Review





Similar Products

94
MedChemExpress hy 50295 galunisertib ly2157299 medchemexpress hy 13226 sis3 medchemexpress hy 13013 dmso tocris
Hy 50295 Galunisertib Ly2157299 Medchemexpress Hy 13226 Sis3 Medchemexpress Hy 13013 Dmso Tocris, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy 50295 galunisertib ly2157299 medchemexpress hy 13226 sis3 medchemexpress hy 13013 dmso tocris/product/MedChemExpress
Average 94 stars, based on 1 article reviews
hy 50295 galunisertib ly2157299 medchemexpress hy 13226 sis3 medchemexpress hy 13013 dmso tocris - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
MedChemExpress ly2157299
Ly2157299, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ly2157299/product/MedChemExpress
Average 95 stars, based on 1 article reviews
ly2157299 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
MedChemExpress tβri kinase inhibitor ly2157299
Tβri Kinase Inhibitor Ly2157299, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tβri kinase inhibitor ly2157299/product/MedChemExpress
Average 95 stars, based on 1 article reviews
tβri kinase inhibitor ly2157299 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
MedChemExpress ly2157299 anti mouse pd 1 antibody mce
Ly2157299 Anti Mouse Pd 1 Antibody Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ly2157299 anti mouse pd 1 antibody mce/product/MedChemExpress
Average 95 stars, based on 1 article reviews
ly2157299 anti mouse pd 1 antibody mce - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
MedChemExpress ly ly2157299
Gross observation of TO development during TGF-β inhibition. ( A ) Schematic representation of TO culture and small molecules (SB or LY) treatment. The small molecules were added to the culture on day 5 and continued to be added on subsequent days until the end of the 16-day culture period. ( B ) Representative bright-field images of TiTOs on days 0, 8, and 16 of culture. The images illustrate cellular reorganization with different patterns during 16 days of culture, both with and without TGFβ inhibitors. Distinct compartments were observed only in the treated groups on day 8 and were more prominent on day 16 (red arrows). In contrast, cells in the control group formed compact and dense aggregates with no apparent compartmentalization. (Right panel: High magnification). TO: testicular organoid; TiTO: TGF-β inhibitor-derived testicular organoid; SB: SB431542; LY: <t>LY2157299.</t> Scale bars: 500 μm, high magnification: 200 μm
Ly Ly2157299, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ly ly2157299/product/MedChemExpress
Average 95 stars, based on 1 article reviews
ly ly2157299 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Gross observation of TO development during TGF-β inhibition. ( A ) Schematic representation of TO culture and small molecules (SB or LY) treatment. The small molecules were added to the culture on day 5 and continued to be added on subsequent days until the end of the 16-day culture period. ( B ) Representative bright-field images of TiTOs on days 0, 8, and 16 of culture. The images illustrate cellular reorganization with different patterns during 16 days of culture, both with and without TGFβ inhibitors. Distinct compartments were observed only in the treated groups on day 8 and were more prominent on day 16 (red arrows). In contrast, cells in the control group formed compact and dense aggregates with no apparent compartmentalization. (Right panel: High magnification). TO: testicular organoid; TiTO: TGF-β inhibitor-derived testicular organoid; SB: SB431542; LY: LY2157299. Scale bars: 500 μm, high magnification: 200 μm

Journal: Stem Cell Research & Therapy

Article Title: Harnessing TGF-β signaling to improve testicular organoid development from dissociated testicular cells

doi: 10.1186/s13287-025-04513-0

Figure Lengend Snippet: Gross observation of TO development during TGF-β inhibition. ( A ) Schematic representation of TO culture and small molecules (SB or LY) treatment. The small molecules were added to the culture on day 5 and continued to be added on subsequent days until the end of the 16-day culture period. ( B ) Representative bright-field images of TiTOs on days 0, 8, and 16 of culture. The images illustrate cellular reorganization with different patterns during 16 days of culture, both with and without TGFβ inhibitors. Distinct compartments were observed only in the treated groups on day 8 and were more prominent on day 16 (red arrows). In contrast, cells in the control group formed compact and dense aggregates with no apparent compartmentalization. (Right panel: High magnification). TO: testicular organoid; TiTO: TGF-β inhibitor-derived testicular organoid; SB: SB431542; LY: LY2157299. Scale bars: 500 μm, high magnification: 200 μm

Article Snippet: After 5 days of culture, the medium was supplemented with the TGF-β inhibitors SB (SB431542,10 μM, Cayman) or LY (LY2157299, 5 μM, Medchem Express) for 11 days.

Techniques: Inhibition, Control, Derivative Assay